[Etiological analysis and short-term efficacy evaluation of acute liver failure in children]

W Ma1, J Sun1, X L Wang1

  • 1Department of Pediatric Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Insights

Identifying the cause of acute liver failure in children is crucial for effective treatment. Etiology varies by age, environment, and season, with definite causes improving short-term outcomes.

Area of Science:

  • Pediatrics
  • Hepatology
  • Epidemiology

Background:

  • Acute liver failure (ALF) in children presents diagnostic challenges, with a significant proportion having unknown etiology.
  • Understanding etiological factors is key to optimizing treatment strategies and improving patient prognosis.

Purpose of the Study:

  • To investigate the causes of ALF in children.
  • To analyze the relationship between etiology and demographic/environmental factors.
  • To evaluate the short-term efficacy of treatment based on identified etiology.

Main Methods:

  • Retrospective analysis of 236 pediatric ALF cases diagnosed between November 2011 and November 2019.
  • Statistical analysis of etiological factors, including demographics (age, gender), living environment, and season of onset.
  • Comparison of short-term treatment efficacy between medical and surgical groups, and across different etiological categories.

Main Results:

  • Nearly half (48.31%) of pediatric ALF cases had unknown etiology.
  • Definite etiologies included drugs/toxicants (16.10%), infection (11.44%), congenital/vascular/biliary diseases (9.32%), and others.
  • Etiological distribution showed significant associations with age, living environment, and season, but not gender.
  • Short-term treatment efficacy was significantly better when the etiology was identified, particularly for congenital/vascular/biliary and drug/toxicity-related causes.

Conclusions:

  • A substantial proportion of pediatric acute liver failure cases remain without a clear etiological diagnosis.
  • Etiology is influenced by age, living environment, and season, highlighting the need for tailored diagnostic approaches.
  • Identifying the specific cause of ALF in children significantly enhances short-term treatment outcomes.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
86
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
156
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
92
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
110
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
312
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
111